The role of graft T-cell size in patients receiving alemtuzumab serotherapy for non-malignant disorders: Results of an institutional protocol
Pediatric Hematology Oncology Journal（2023）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined